港股異動 | 閲文集團(0772.HK)漲逾4% 多家機構唱多
格隆匯4月22日丨閲文集團(0772.HK)漲逾4%,報84.35港元,股價創近2個月新高,總市值859億港元。瑞士信貸發表最新研究報吿稱,考慮強勁盈利增長及高可見度,首予閲文集團(00772.HK)跑贏大市評級,目標價98港元,相當於明年預測市盈率43倍。報吿稱,閲文是內地領先線上內容供應商及營運商。公司累積龐大用户基礎,內容接觸面廣,提供頂級文學IP。中信證券表示,隨着騰訊大文娛組織結構調整,騰訊大文娛將進入增長快車道。程武團隊對於閲文集團IP運營的戰略改革逐步落地,公司版權運營效率有望顯著提升,長期看好閲文作為騰訊大文娛生態源頭活水的價值,維持閲文集團“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.